These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 17996928)
1. Deletion of Melanin-Concentrating Hormone Receptor-1 gene accentuates D-amphetamine-induced psychomotor activation but neither the subsequent development of sensitization nor the expression of conditioned activity in mice. Tyhon A; Lakaye B; Grisar T; Tirelli E Pharmacol Biochem Behav; 2008 Feb; 88(4):446-55. PubMed ID: 17996928 [TBL] [Abstract][Full Text] [Related]
2. Mice lacking the melanin-concentrating hormone receptor-1 exhibit an atypical psychomotor susceptibility to cocaine and no conditioned cocaine response. Tyhon A; Adamantidis A; Foidart A; Grisar T; Lakaye B; Tirelli E Behav Brain Res; 2006 Oct; 173(1):94-103. PubMed ID: 16839618 [TBL] [Abstract][Full Text] [Related]
3. Amphetamine- and cocaine-induced conditioned place preference and concomitant psychomotor sensitization in mice with genetically inactivated melanin-concentrating hormone MCH(1) receptor. Tyhon A; Lakaye B; Adamantidis A; Tirelli E Eur J Pharmacol; 2008 Dec; 599(1-3):72-80. PubMed ID: 18848539 [TBL] [Abstract][Full Text] [Related]
4. Behavioral and biochemical responses to d-amphetamine in MCH1 receptor knockout mice. Smith DG; Qi H; Svenningsson P; Wade M; Davis RJ; Gehlert DR; Nomikos GG Synapse; 2008 Feb; 62(2):128-36. PubMed ID: 18000809 [TBL] [Abstract][Full Text] [Related]
7. Role of D1-like receptors in amphetamine-induced behavioral sensitization: a study using D1A receptor knockout mice. Karper PE; De la Rosa H; Newman ER; Krall CM; Nazarian A; McDougall SA; Crawford CA Psychopharmacology (Berl); 2002 Feb; 159(4):407-14. PubMed ID: 11823893 [TBL] [Abstract][Full Text] [Related]
8. Differences in behavioural effects of amphetamine and dopamine-related gene expression in wild-type and homozygous CCK2 receptor deficient mice. Rünkorg K; Värv S; Matsui T; Kõks S; Vasar E Neurosci Lett; 2006 Oct; 406(1-2):17-22. PubMed ID: 16916582 [TBL] [Abstract][Full Text] [Related]
9. Cocaine- and amphetamine-regulated transcript (CART) peptides modulate the locomotor and motivational properties of psychostimulants. Couceyro PR; Evans C; McKinzie A; Mitchell D; Dube M; Hagshenas L; White FJ; Douglass J; Richards WG; Bannon AW J Pharmacol Exp Ther; 2005 Dec; 315(3):1091-100. PubMed ID: 16099925 [TBL] [Abstract][Full Text] [Related]
11. Dual alteration of limbic dopamine D1 receptor-mediated signalling and the Akt/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization. Chen PC; Lao CL; Chen JC J Neurochem; 2007 Jan; 100(1):225-41. PubMed ID: 17101033 [TBL] [Abstract][Full Text] [Related]
12. [Effects of antagonists of the various subtypes of dopamine receptors on the locomotor activity of C57BL mice induced by psychostimulators]. Novoselov IA; Raevskiĭ KS Eksp Klin Farmakol; 2003; 66(6):3-5. PubMed ID: 14743700 [TBL] [Abstract][Full Text] [Related]
14. Mu-opioid receptor knockout mice show diminished food-anticipatory activity. Kas MJ; van den Bos R; Baars AM; Lubbers M; Lesscher HM; Hillebrand JJ; Schuller AG; Pintar JE; Spruijt BM Eur J Neurosci; 2004 Sep; 20(6):1624-32. PubMed ID: 15355329 [TBL] [Abstract][Full Text] [Related]
15. Maternal immune activation in late gestation enhances locomotor response to acute but not chronic amphetamine treatment in male mice offspring: role of the D1 receptor. Zager A; Mennecier G; Palermo-Neto J Behav Brain Res; 2012 Jun; 232(1):30-6. PubMed ID: 22487249 [TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system. Kõks S; Volke V; Veraksits A; Rünkorg K; Sillat T; Abramov U; Bourin M; Huotari M; Männistö PT; Matsui T; Vasar E Psychopharmacology (Berl); 2001 Nov; 158(2):198-204. PubMed ID: 11702094 [TBL] [Abstract][Full Text] [Related]
17. Amphetamine regulates NR2B expression in Go2α knockout mice and thereby sustains behavioral sensitization. Brunk I; Sanchis-Segura C; Blex C; Perreau-Lenz S; Bilbao A; Spanagel R; Ahnert-Hilger G J Neurochem; 2010 Oct; 115(1):234-46. PubMed ID: 20649838 [TBL] [Abstract][Full Text] [Related]
18. Dietary cadmium exposure attenuates D-amphetamine-evoked [3H]dopamine release from striatal slices and methamphetamine-induced hyperactivity. Miller DK; Dopheide MM; Smith SM; Casteel SW Pharmacol Biochem Behav; 2005 Apr; 80(4):557-66. PubMed ID: 15820525 [TBL] [Abstract][Full Text] [Related]
19. Characterization of behavioral response to amphetamine, tyrosine hydroxylase levels, and dopamine receptor levels in neurokinin 3 receptor knockout mice. Nordquist RE; Savignac H; Pauly-Evers M; Walker G; Knoflach F; Borroni E; Glaentzlin P; Bohrmann B; Messer J; Ozmen L; Albientz A; Spooren W Behav Pharmacol; 2008 Sep; 19(5-6):518-29. PubMed ID: 18690106 [TBL] [Abstract][Full Text] [Related]
20. Lack of effect of a glycine(B) receptor partial agonist on amphetamine-induced sensitization in mice. Przegaliński E; Siwanowicz J; Chojnacka-Wójcik E Pol J Pharmacol; 1999; 51(5):385-90. PubMed ID: 10817538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]